Literature DB >> 17924174

Comparison of two methods of future liver remnant volume measurement.

Yun Shin Chun1, Dario Ribero, Eddie K Abdalla, David C Madoff, Melinda M Mortenson, Steven H Wei, Jean-Nicolas Vauthey.   

Abstract

BACKGROUND: In liver transplantation, a minimum graft to patient body weight (BW) ratio is required for graft survival; in liver resection, total liver volume (TLV) calculated from body surface area (BSA) is used to determine the future liver remnant (FLR) volume needed for safe hepatic resection. These two methods of estimating liver volume have not previously been compared. The purpose of this study was to compare FLR volumes standardized to BW versus BSA and to assess their utility in predicting postoperative hepatic dysfunction after hepatic resection.
METHODS: Records were reviewed of 68 consecutive noncirrhotic patients who underwent major hepatectomy after portal vein embolization between 1998 and 2006. FLR (cubic centimeter) was measured preoperatively with three-dimensional helical computed tomography; TLV (cubic centimeter) was calculated from the patients' BSA. The relationship between FLR/TLV and FLR/BW (cubic centimeter per kilogram) was examined using linear regression analysis. Receiver operating characteristic (ROC) curve analysis was used to determine FLR/TLV and FLR/BW cutoff values for predicting postoperative hepatic dysfunction (defined as peak bilirubin level>3 mg/dl or prothrombin time>18 s).
RESULTS: Regression analysis revealed that the FLR/TLV and FLR/BW ratios were highly correlated (Pearson correlation coefficient, 0.98). The area under the ROC curve was 0.85 for FLR/TLV and 0.84 for FLR/BW (95% confidence interval, 0.71-0.97). Sixteen of the 68 patients developed postoperative hepatic dysfunction. The ROC curve analysis yielded a cutoff FLR/BW value of <or=0.4, which had a positive predictive value (PPV) of 78% and a negative predictive value (NPV) of 85%. The corresponding FLR/TLV cutoff value of <or=20% had a PPV of 80% and a NPV of 86%.
CONCLUSIONS: Based on the strong correlation between the FLR measurements standardized to BW and BSA and their similar ability to predict postoperative hepatic dysfunction, both methods are appropriate for assessing liver volume. In noncirrhotic patients, a FLR/BW ratio of <or=0.4 and FLR/TLV of <or=20% provide equivalent thresholds for performing safe hepatic resection.

Entities:  

Mesh:

Year:  2007        PMID: 17924174     DOI: 10.1007/s11605-007-0323-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  31 in total

1.  Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations.

Authors:  J N Vauthey; A Chaoui; K A Do; M M Bilimoria; M J Fenstermacher; C Charnsangavej; M Hicks; G Alsfasser; G Lauwers; I F Hawkins; J Caridi
Journal:  Surgery       Date:  2000-05       Impact factor: 3.982

Review 2.  Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care.

Authors:  David C Madoff; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  J Vasc Interv Radiol       Date:  2005-06       Impact factor: 3.464

3.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

4.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

Review 5.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

6.  Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume.

Authors:  K Shirabe; M Shimada; T Gion; H Hasegawa; K Takenaka; T Utsunomiya; K Sugimachi
Journal:  J Am Coll Surg       Date:  1999-03       Impact factor: 6.113

7.  Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

Authors:  Thomas Aloia; Mylène Sebagh; Marylène Plasse; Vincent Karam; Francis Lévi; Sylvie Giacchetti; Daniel Azoulay; Henri Bismuth; Denis Castaing; René Adam
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

8.  Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion.

Authors:  K Uesaka; Y Nimura; M Nagino
Journal:  Ann Surg       Date:  1996-01       Impact factor: 12.969

9.  Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection.

Authors:  Margo Shoup; Mithat Gonen; Michael D'Angelica; William R Jarnagin; Ronald P DeMatteo; Lawrence H Schwartz; Scott Tuorto; Leslie H Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003 Mar-Apr       Impact factor: 3.452

10.  Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.

Authors:  Dieter C Broering; Christian Hillert; Gerrit Krupski; Lutz Fischer; Lars Mueller; Eike G Achilles; Jan Schulte am Esch; Xavier Rogiers
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

View more
  35 in total

1.  Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes?

Authors:  Onur Yaprak; Necdet Guler; Gulum Altaca; Murat Dayangac; Tolga Demirbas; Murat Akyildiz; Levent Ulusoy; Yaman Tokat; Yildiray Yuzer
Journal:  HPB (Oxford)       Date:  2012-07       Impact factor: 3.647

2.  Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.

Authors:  Universe Leung; Amber L Simpson; Raphael L C Araujo; Mithat Gönen; Conor McAuliffe; Michael I Miga; E Patricia Parada; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; Yuman Fong; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-06-25       Impact factor: 6.113

Review 3.  Liver resection and transplantation in hepatocellular carcinoma.

Authors:  J Belghiti; D Fuks
Journal:  Liver Cancer       Date:  2012-09       Impact factor: 11.740

4.  Definition of Readmission in 3,041 Patients Undergoing Hepatectomy.

Authors:  Kristoffer W Brudvik; Yoshihiro Mise; Claudius Conrad; Giuseppe Zimmitti; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2015-02-28       Impact factor: 6.113

5.  Anatomic resection of liver segments 6-8 for hepatocellular carcinoma.

Authors:  Chang-Ku Jia; Jie Weng; You-Ke Chen; Yu Fu
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

6.  Standardized liver volumetry for portal vein embolization.

Authors:  Dario Ribero; Yun Shin Chun; Jean-Nicolas Vauthey
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

Review 7.  Hepatocellular carcinoma: Advances in diagnosis, management, and long term outcome.

Authors:  Adam S Bodzin; Ronald W Busuttil
Journal:  World J Hepatol       Date:  2015-05-28

8.  Liver function following extended hepatectomy can be accurately predicted using remnant liver volume to body weight ratio.

Authors:  Stéphanie Truant; Emmanuel Boleslawski; Géraldine Sergent; Emmanuelle Leteurtre; Alain Duhamel; Mohamed Hebbar; François-René Pruvot
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

9.  Are two-stage hepatectomies associated with more complications than one-stage procedures?

Authors:  Erik Schadde; Ksenija Slankamenac; Stefan Breitenstein; Mickael Lesurtel; Michelle De Oliveira; Beatrice Beck-Schimmer; Philipp Dutkowski; Pierre-Alain Clavien
Journal:  HPB (Oxford)       Date:  2012-11-28       Impact factor: 3.647

10.  Comparison of Survival Outcomes Between Right Posterior Sectionectomy and Right Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Liver: A Single-Centre Experience.

Authors:  Vincent S K Yip; Ronnie T P Poon; Kenneth S H Chok; Albert C Y Chan; Wing Chiu Dai; Simon H Y Tsang; See Ching Chan; Chung Mau Lo; Tan To Cheung
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.